Literature DB >> 2977271

How would you like to have an orchidectomy for advanced prostatic cancer?

H Parmar1, R H Phillips, S L Lightman, L Edwards.   

Abstract

One hundred thirteen patients were randomized for the study. There was no significant difference between the groups for response or survival. The incidence of side effects related to the reduction of testosterone was similar in both groups. Disease "flare" was seen in three patients treated with long-acting D-Trp-6 LH-RH. All symptoms resolved by the end of 8 weeks. There was less psychological morbidity in the D-Trp-6 LH-RH group but the difference did not reach statistical significance. Our results indicate that long-acting D-Trp-6 LH-RH offers a safe and effective alternative to surgical orchidectomy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2977271     DOI: 10.1097/00000421-198801102-00038

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  3 in total

Review 1.  Overview of the current status of total androgen deprivation in metastasized prostate cancer.

Authors:  F M Debruyne; W P Witjes
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

2.  Patients' and doctors' perception of long-term morbidity in patients with testicular cancer clinical stage I. A descriptive pilot study.

Authors:  S D Fosså; C Moynihan; S Serbouti
Journal:  Support Care Cancer       Date:  1996-03       Impact factor: 3.603

3.  Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group.

Authors:  B R Cassileth; M S Soloway; N J Vogelzang; J M Chou; P D Schellhammer; E J Seidmon; G T Kennealey
Journal:  Qual Life Res       Date:  1992-10       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.